Clinical Trial Update: Sorafenib and Radiotherapy in the Treatment of Invasive Bladder Cancer With Conservative Intent [Phase 1]

View source ↗

Summary

A Phase 1 trial assessing the combination of sorafenib with radiotherapy for invasive bladder cancer treated with bladder-sparing intent; the study has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: Spanish Oncology Genito-Urinary Group | Conditions: Bladder Cancer | Phase 1 | Status: COMPLETED